FDA Going Digital

With a new effort, the US Food and Drug Administration is hoping to keep up with the onslaught of new products that rely on machine learning and similar approaches to gauge which people are sick, Wired reports. And these products can reach the regulatory approval stage faster than more traditional medical devices, it adds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.